Liquid biopsies are non-invasive methods for diagnostics to detect early stage cancer resulting in more successful treatment. One liquid biopsy technique is the detection of RNA from tumor derived exosomes. Join our webinar to learn how bioinformatics solutions can be used to analyze and interpret RNA-sequencing results from these exosome experiments, providing additional hypothesis on regulatory networks and potential isoforms of biological significance.
When: Tuesday, April 5, 8:00 a.m. – 8:45 a.m. (PST) / 5:00 p.m. – 5:45 p.m. (CEST)
Title: Transcriptome analysis of pancreatic cancer exosomes reveal pathways and biological processes involved in metastatic progressionREDISTER
Find out how to:
- Streamline RNA-sequencing alignment and analysis using configured workflows for the fast track to biological interpretation
- Analyze exosome gene expression signatures to pinpoint significant genes associated with early detection of pancreatic cancer
- Identify significantly differentially expressed isoforms and their association to pancreatic cancer
- Generate novel regulatory networks as hypotheses suggesting drivers of the expression changes observed in these tumor producing exosomes to better understand pancreatic cancer drivers.